Products are selected by our editors, we may earn commission from links on this page.

A new lawsuit alleging the presence of “forever chemicals” in tampons has intensified public attention on menstrual product safety. The lawsuit, filed by several women in California against multiple manufacturers, claims that long-term use of certain products exposed consumers to per- and polyfluoroalkyl substances (PFAS), a group of chemicals commonly known as “forever chemicals” because they break down very slowly in the environment and the human body.
The legal action comes as researchers, including scientists affiliated with Harvard and other institutions, continue studying the potential health effects of PFAS exposure. While PFAS have been linked to a variety of health concerns in some studies, researchers emphasize that more work is needed to determine how much exposure may come from menstrual products and what that means for long-term health.
For consumers, the latest lawsuit raises important questions about product transparency, ingredient disclosure, and how menstrual products are regulated in the United States.
What The Lawsuit And Research Are About

The lawsuit alleges that several well-known menstrual product manufacturers sold tampons and related products containing PFAS and other potentially harmful substances without adequately informing consumers. The plaintiffs claim they experienced reproductive health problems after years of using the products, although the allegations have not been proven in court.
PFAS are used in a wide variety of consumer products because they resist water, oil, and stains. Scientists have detected certain PFAS compounds in drinking water, food packaging, cookware, cosmetics, and other everyday items. Because these chemicals persist for long periods, they have become the subject of growing environmental and public health research.
Researchers are particularly interested in menstrual products because vaginal tissue is highly absorbent, meaning chemicals that come into contact with these tissues could potentially be absorbed differently than through skin exposure. However, experts stress that detecting PFAS in a product does not automatically mean it poses a measurable health risk. More research is needed to determine actual exposure levels and whether they are sufficient to affect human health.
Why Scientists Want More Oversight

The recent lawsuit follows a broader push for greater transparency surrounding menstrual products. In recent years, lawmakers have proposed requiring manufacturers to disclose more ingredients, while researchers have called for additional independent testing of tampons, pads, and similar products. Some states have already adopted ingredient disclosure requirements for intentionally added substances.
Harvard environmental health researchers and other scientists have spent years studying PFAS because some compounds have been associated with higher cholesterol, immune system effects, thyroid disease, reduced fertility, certain pregnancy complications, and increased risks of some cancers after prolonged exposure. At the same time, researchers caution that not every PFAS behaves the same way, and exposure levels matter significantly when evaluating potential health risks.
Regulatory agencies continue evaluating new research as it becomes available. Experts say additional studies will help clarify how much PFAS exposure, if any, comes from menstrual products compared with other everyday sources such as food, drinking water, and household items.
What Consumers Should Know

Health experts emphasize that the current lawsuit should not be interpreted as proof that all tampons are unsafe. The litigation is ongoing, and many of the scientific questions surrounding PFAS exposure from menstrual products remain under investigation. Courts will ultimately evaluate the legal claims, while researchers continue gathering evidence about potential health effects.
Consumers who are concerned about chemical exposure can read product labels carefully, follow updates from trusted public health agencies, and discuss any health concerns with their healthcare provider. Some manufacturers also offer products made with organic cotton or publish additional information about materials used in their products, although consumers should remember that marketing claims vary between brands.
Ultimately, the lawsuit has renewed an important conversation about product safety, transparency, and scientific research. As researchers continue studying PFAS and regulators review emerging evidence, consumers can expect greater attention to ingredient disclosure and menstrual product testing in the years ahead.
